Global Arena Holding Inc.
GAHC
$0.00
$0.000.00%
| Weiss Ratings | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -3.42 | |||
| Price History | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -100.00% | |||
| 90-Day Total Return | -100.00% | |||
| Year to Date Total Return | -100.00% | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.75% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jan 21, 2025 | |||
| 52-Week High Price (Date) | Mar 25, 2024 | |||
| Valuation | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.70K | |||
| Enterprise Value | 4.86M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -91.55% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 4.57 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -152.38 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.48B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 646 801 5524 | |||
| Address | 208 East 51 Street New York, NY 10022 | |||
| Website | gahc.info | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -3.00% | |||
| Profit Margin | -61.65% | |||
| Management Effectiveness | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -3.29% | |||
| Return on Equity | -- | |||
| Income Statement | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.06M | |||
| Total Revenue (TTM) | 1.06M | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 956.80K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -31.90K | |||
| Net Income (TTM) | -655.30K | |||
| Net Income Avl. to Common (TTM) | -655.30K | |||
| Total Revenue Growth (Q YOY) | 46.30% | |||
| Earnings Growth (Q YOY) | 47.42% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 83.33% | |||
| Balance Sheet | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 30.40K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 30.40K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -9.32M | |||
| Current Ratio (Q) | 0.003 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 596.60K | |||
| Total Current Liabilities (Q) | 9.91M | |||
| Total Debt (Q) | 4.91M | |||
| Total Liabilities (Q) | 9.91M | |||
| Total Common Equity (Q) | -9.29M | |||
| Cash Flow | GAHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 301.20K | |||
| Net Change in Cash (TTM) | -15.50K | |||
| Levered Free Cash Flow (TTM) | -161.50K | |||
| Cash from Operations (TTM) | -316.70K | |||
